ImmunoCellular (IMUC)

Add to Watchlists
Create an Alert
1.16 +0.02  +1.75% AMEX Apr 16, 5:00PM BATS Real time Currency in USD
View Full Chart
IMUC Price Chart
View All Events

IMUC Events

Date Type Description
Sep 20 Misc AGM Event for Immunocellular Therapeutics Ltd
View All Performance Charts

IMUC Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). ImmunoCellular is down 51.26% over the last year vs S&P 500 Total Return up 22.52%, Northwest Biotherapeutics up 42.39%, and CytRx up 7.53%.

Get Quote for

Portfolio Strategies Featuring IMUC

Did ImmunoCellular make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

IMUC Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Industry Code: 5417
  • NAICS Sector: Professional, Scientific, and Technical Services
  • NAICS Sector Code: 54

ImmunoCellular Therapeutics Limited is a clinical-stage biotechnology company that develops immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.

Recent Quotes

Symbol Price Chg Chg % Market Cap
IMUC 1.16 +0.02 +1.75% 66.78M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.